Anadys Pharmaceuticals to Present at BIOCOM Investor Conference 2008

Anadys Pharmaceuticals, Inc. announced today that it will present at the 3rd annual BIOCOM Investor Conference on Monday, October 27, 2008 at 11:30 a.m. PDT at the Hyatt Regency La Jolla in San Diego, California. Steve Worland, Ph.D., President and Chief Executive Officer of Anadys, will present an overview of Anadys and its three clinical programs: ANA598 and ANA773 in hepatitis C and ANA773 in cancer. The... 

Tags: Anadys Pharmaceuticals Inc., biopharmaceutical, California, cancer, chronic hepatitis C, hepatitis C, Hyatt Regency La Jolla, San Diego, Securities and Exchange Commission, Steve Worland, treatment of cancer

Admitting crisis, leaders stress need for education, action on ethics

At Thursday’s summit on health care ethics, Dr. Lawrence Sands, middle row from left, chief health officer of the Southern Nevada Health District; Denise Selleck-Davis, executive director of the Nevada Osteopathic Medical Association; Larry Matheis, executive director of the Nevada State Medical Association, and state Sen. Joe Heck. If Nevada’s ailing health care system is to be healed, it must... 

Tags: breast cancer, Catherine Cortez Masto, Denise Selleck-Davis, federal law, hepatitis C, Ihsan Azzam, Internet-based ethics resource, Joe Heck, Larry Matheis, Las Vegas, Lawrence Sands, Michael Jackson, Nevada, Nevada Center for Ethics & Health Policy, Nevada Osteopathic Medical Association, Nevada State Medical Association, Nevada State Medical Examiners Board, Southern Nevada Health District, state health division, The Sun

anadys pharmaceuticals, biocom investor conference, kuwait oil company nurses, kuwait oil company nurse forum, nursing jobs philis